Work

A Phase II Study of AT-101 to Overcome Bcl-2–Mediated Resistance to Androgen Deprivation Therapy in Patients With Newly Diagnosed Castration-Sensitive Metastatic Prostate Cancer

Year: 2015

Type: article

Study design: Clinical Trial

Source: Clinical Genitourinary Cancer

DOI: 10.1016/j.clgc.2015.09.010

Authors: Mark N. Stein, Maha Hussain, Walter M. Stadler, Glenn Liu, Irina V. Tereshchenko, Susan Goodin, Chandrika Jeyamohan, Howard L. Kaufman, Janice Mehnert, Robert S. DiPaola

Institutions: Rutgers Cancer Institute, University of Michigan, University of Chicago, University of Wisconsin–Madison, University of Wisconsin Carbone Cancer Center

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: U.S. Department of Defense, National Institutes of Health, National Cancer Institute

Awards: G1387911743, G2600762411, G3398658105, G375300792, G4821755765, G6525229096, CINJ CLINICAL CONSORTIUM FOR PROSTATE CANCER RESEARCH, G7143252420, G9000085572, G9000111467, Cancer Center Support Grant

OpenAlex ID: W1807250471

FWCI: 2.614

Cites: 21

Cited by: 51

Related to: 10